Richard Pfenniger Net Worth
The estimated Net Worth of Richard C Jr Pfenniger is at least $274 Thousand dollars as of 25 October 2019. Mr. Pfenniger owns over 25,000 units of TransEnterix stock worth over $76,725 and over the last 15 years he sold TRXC stock worth over $0. In addition, he makes $197,120 as Independent Director at TransEnterix.
Mr. Pfenniger TRXC stock SEC Form 4 insider trading
Richard has made over 7 trades of the TransEnterix stock since 2012, according to the Form 4 filled with the SEC. Most recently he bought 25,000 units of TRXC stock worth $36,250 on 25 October 2019.
The largest trade he’s ever made was buying 100,000 units of TransEnterix stock on 16 May 2017 worth over $54,000. On average, Richard trades about 4,189 units every 31 days since 2005. As of 25 October 2019 he still owns at least 275,000 units of TransEnterix stock.
You can see the complete history of Mr. Pfenniger stock trades at the bottom of the page.
Richard Pfenniger biography
Richard C. Pfenniger, Jr., is Independent Director of the Company, since April 12, 2005. Currently, Mr. Pfenniger is currently a private investor. Previously, he served as the Interim CEO of Vein Clinics of America, Inc., a privately held company, from May 2014 through February 2015, as the Interim CEO of IntegraMed America, Inc., a privately held company (IntegraMed), from January 2013 through June 2013, as Chief Executive Officer and President of Continucare Corporation, a provider of physician services, from October 2003 until December 2011, and the Chairman of Continucare’s board of directors from September 2002 until December 2011. Additionally, Mr. Pfenniger served as CEO and Vice Chairman of Whitman Education Group, Inc., a post-secondary education provider, from 1997 until 2003. From 1994 to 1997, Mr. Pfenniger served as Chief Operating Officer of IVAX Corporation, and from 1989 to 1994 he served as Senior Vice President-Legal Affairs and General Counsel of IVAX Corporation. Prior to that, Mr. Pfenniger was engaged in the private practice of law, and earlier in his career, Mr. Pfenniger worked as a C.P.A. with Price Waterhouse & Co. Mr. Pfenniger is a director of OPKO Health, Inc., GP Strategies, Inc., Wright Investors’ Services Holdings, Inc. and BioCardia, Inc., each a publicly-held company, and IntegraMed America. Mr. Pfenniger is a member and chair of the audit committee of each of GP Strategies, Inc. and OPKO Health, Inc.. Mr. Pfenniger received his B.B.A. from Florida Atlantic University and his J.D. from the University of Florida. As a result of Mr. Pfenniger’s multi-faceted experience as a chief executive officer, chief operating officer and general counsel, he is able to provide valuable business, leadership and management advice to the Board in many critical areas. In addition, Mr. Pfenniger’s knowledge of the healthcare business has given him insight into many aspects of our business.
What is the salary of Richard Pfenniger?
As the Independent Director of TransEnterix, the total compensation of Richard Pfenniger at TransEnterix is $197,120. There are 5 executives at TransEnterix getting paid more, with Todd Pope having the highest compensation of $3,564,940.
How old is Richard Pfenniger?
Richard Pfenniger is 63, he’s been the Independent Director of TransEnterix since 2005. There are 3 older and 8 younger executives at TransEnterix. The oldest executive at TransEnterix, Inc. is William Kelley, 78, who is the Independent Director.
What’s Richard Pfenniger’s mailing address?
Richard’s mailing address filed with the SEC is OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI, FL, 33137.
Insider trading at TransEnterix
Over the last 6 years, insiders at TransEnterix have traded over $32,344,179 worth of TransEnterix stock and bought 6,454,685 units worth $15,346,279 . The most active insider traders include Jane Ph D Hsiao, William N Jr Starling, and S.P.A Sofar,. On average, TransEnterix executives and independent directors trade stock every 36 days with the average trade being worth of $86,181. The most recent stock trade was executed by Todd Pope on 14 May 2019, trading 71,943 units of TRXC stock currently worth $100,001.
What does TransEnterix do?
TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also provides SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.
What does TransEnterix’s logo look like?
Complete history of Mr. Pfenniger stock trades at OPKO Health, GP Strategies, TransEnterix, and BioCardia
TransEnterix executives and stock owners
TransEnterix executives and other stock owners filed with the SEC include:
- Todd Pope, President, Chief Executive Officer, Director
- Eric Smith, Chief Commercial Officer
- Joseph Slattery, Chief Financial Officer, Executive Vice President
- Anthony Fernando, Chief Operating Officer
- Paul LaViolette, Chairman, Independent Director
- Richard Pfenniger, Independent Director
- Aftab Kherani, Independent Director
- David Milne, Independent Director
- William Kelley, Independent Director
- Jane Hsiao, Independent Director
- Andrea Biffi, Independent Director
- William Starling, Independent Director
- Willam N Kelley, Director
- S.P.A Sofar,, 10% owner
- Capital Iii Lp Aisling Capi…,
- Iv, Llcsv Life Sciences Fun…,
- Dennis Dougherty, Director
- Richard Mueller, Chief Operating Officer